ArticlePharmaceutics2021

Systemically Administered Homing Peptide Targets Dystrophic Lesions and Delivers Transforming Growth Factor-β (TGFβ) Inhibitor to Attenuate Murine Muscular Dystrophy Pathology.

Aqsa Iqbal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.